| |
| |
|
| Insider
Information: |
Pauwels Eric |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
97,694 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,661,596 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
97,694 |
|
|
| Total
Value |
$2,661,596 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
19
|
|
Stock
price went up :
|
0
|
9
|
| Stock
price went down : |
0
|
10
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -236.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Accuray Inc |
ARAY |
SVP Chief Marketing Of... |
2011-02-28 |
30,000 |
2011-02-28 |
0 |
Premium* |
|
|
NPS Pharmaceuticals Inc |
NPSP |
President, NPS Pharma ... |
2015-02-21 |
0 |
2011-09-26 |
0 |
Premium* |
|
|
PTC Therapeutics, Inc. |
PTCT |
|
2024-04-17 |
67,694 |
2020-04-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
49 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PTCT |
PTC Therapeutics, Inc. |
CHIEF BUSINESS OFFICER |
• – – |
2023-01-11 |
4 |
S |
$44.36 |
$25,329 |
D/D |
(571) |
66,271 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Business Officer |
• – – |
2021-01-25 |
4 |
S |
$62.05 |
$26,745 |
D/D |
(431) |
36,849 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF BUSINESS OFFICER |
• – – |
2023-01-10 |
4 |
S |
$42.93 |
$28,465 |
D/D |
(663) |
66,842 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Business Officer |
• – – |
2022-01-04 |
4 |
S |
$41.16 |
$33,177 |
D/D |
(806) |
35,386 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Business Officer |
• – – |
2022-01-07 |
4 |
S |
$38.53 |
$33,363 |
D/D |
(866) |
34,520 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF BUSINESS OFFICER |
• – – |
2022-04-19 |
4 |
S |
$42.52 |
$34,947 |
D/D |
(822) |
49,772 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF BUSINESS OFFICER |
• – – |
2023-01-09 |
4 |
S |
$41.66 |
$35,741 |
D/D |
(858) |
67,505 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Business Officer |
• – – |
2021-04-19 |
4 |
S |
$48.17 |
$37,860 |
D/D |
(786) |
35,701 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF BUSINESS OFFICER |
• – – |
2023-04-18 |
4 |
S |
$52.04 |
$38,096 |
D/D |
(732) |
64,805 |
0 |
% |
|
| NPSP |
NPS Pharmaceuticals Inc |
President, NPS Pharma Intl |
• – – |
2015-02-12 |
4 |
D |
$45.85 |
$43,878 |
D/D |
(957) |
24,934 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF BUSINESS OFFICER |
• – – |
2024-01-08 |
4 |
S |
$28.64 |
$44,937 |
D/D |
(1,569) |
46,612 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF BUSINESS OFFICER |
• – – |
2023-05-18 |
4 |
AS |
$58.71 |
$46,267 |
D/D |
(788) |
55,969 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF BUSINESS OFFICER |
• – – |
2024-01-09 |
4 |
S |
$29.01 |
$59,916 |
D/D |
(2,065) |
44,547 |
0 |
% |
|
| NPSP |
NPS Pharmaceuticals Inc |
SVP & Chief Commercial Officer |
• – – |
2014-02-07 |
4 |
D |
$35.13 |
$61,794 |
D/D |
(1,759) |
23,632 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Business Officer |
• – – |
2021-01-05 |
4 |
S |
$62.37 |
$66,549 |
D/D |
(1,067) |
27,080 |
0 |
% |
|
| NPSP |
NPS Pharmaceuticals Inc |
President, NPS Pharma Intl |
• – – |
2015-02-07 |
4 |
D |
$45.85 |
$76,203 |
D/D |
(1,662) |
23,104 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
SVP & Chief Commercial Officer |
• – – |
2014-02-13 |
4 |
D |
$38.30 |
$108,312 |
D/D |
(2,828) |
28,904 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF BUSINESS OFFICER |
• – – |
2023-05-22 |
4 |
AS |
$58.98 |
$118,791 |
D/D |
(2,013) |
47,553 |
0 |
% |
|
| NPSP |
NPS Pharmaceuticals Inc |
President, NPS Pharma Intl |
• – – |
2015-02-13 |
4 |
D |
$45.88 |
$137,869 |
D/D |
(3,005) |
30,029 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
President, NPS Pharma Intl |
• – – |
2014-09-26 |
4 |
D |
$27.55 |
$142,847 |
D/D |
(5,185) |
24,766 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Business Officer |
• – – |
2020-11-03 |
4 |
AS |
$56.50 |
$349,961 |
D/D |
(6,194) |
27,647 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF BUSINESS OFFICER |
• – – |
2023-05-19 |
4 |
AS |
$58.96 |
$377,491 |
D/D |
(6,403) |
49,566 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF BUSINESS OFFICER |
• – – |
2023-05-17 |
4 |
AS |
$58.50 |
$470,822 |
D/D |
(8,048) |
56,757 |
0 |
% |
|
| NPSP |
NPS Pharmaceuticals Inc |
President, NPS Pharma Intl |
• – – |
2015-02-21 |
4 |
D |
$46.00 |
$1,381,334 |
D/D |
(30,029) |
0 |
0 |
- |
|
49 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
